Barbara A. Goff

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 7 papers. Top paper: “Extraordinary clinical response to ibrutinib in low-grade ovarian cancer guided by organoid drug testing”.

Extraordinary clinical response to ibrutinib in low-grade ovarian cancer guided by organoid drug testing

npj Precision Oncology(2023)10.1038/s41698-023-00379-8

N/A

0.500DataRank · unranked

27 citations

Payel Chatterjee, Rachele Rosati, Lauren R. Appleyard, Grace J. Durenberger, Robert L. Diaz +14 more

Treatment delay and prolongation in locally advanced cervical cancer

Gynecologic Oncology Reports(2025)10.1016/j.gore.2025.102004

N/A

0.165DataRank · unranked

2 citations

Yuexin Wang, Barbara A. Goff, Ting Martin, Kylie H. Kang, Kemi M. Doll +2 more

Intraperitoneal immunotherapy with denileukin diftitox (ONTAK) in recurrent refractory ovarian cancer

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.09.019

N/A

0.113DataRank · unranked

1 citations

Nikita S Jejurikar, Katie M Hitchcock-Bernhardt, William R. Gwin, Jessica Reichow, Yushe Dang +7 more

BET, SRC, and BCL2 family inhibitors are synergistic drug combinations with PARP inhibitors in ovarian cancer

EBioMedicine(2020)10.1016/j.ebiom.2020.102988

N/A

0DataRank · unranked

38 citations

Reid Shaw, Franz X. Schaub, Isabella N. Stork, Kay E. Gurley, Caroline Bridgwater +11 more

Scholarly activity following National Institutes of Health Women’s Reproductive Health Research K12 training—a cohort study

American Journal of Obstetrics and Gynecology(2023)10.1016/j.ajog.2023.06.050

N/A

0DataRank · unranked

4 citations

Ronit Katz, Diana Louden, Emiko Oshima, Amy Murtha, Cynthia Gyamfi-Bannerman +6 more

Characterization of the Early Years of Bevacizumab Use for First-Line Treatment of Ovarian Cancer in the United States

JCO Oncology Practice(2021)10.1200/op.20.00918

N/A

0DataRank · unranked

2 citations

Barbara A. Goff, Heidi J. Gray, Daniel A. Enquobahrie, Kemi M. Doll, Soledad Jorge

Uterine Lavage Identifies Cancer Mutations and Increased TP53 Somatic Mutation Burden in Individuals with Ovarian Cancer

Cancer Research Communications(2022)10.1158/2767-9764.crc-22-0314

N/A

0DataRank · unranked

11 citations

Brendan Kohrn, Jeanne Fredrickson, Enna Manhardt, Marc R. Radke, Ronit Katz +13 more